Nourkrin is a specialized oral supplement brand focused on hair growth and loss, built around marine-derived proteoglycans, specifically its proprietary Marilex® complex. The brand positions itself as offering a drug-free, nutritional approach to supporting the normal hair-growth cycle, distinguishing it from conventional pharmaceutical treatments for hair loss. 1

The company describes itself as a globally recognized entity with research focusing on the relationship between proteoglycans and the hair follicle. In Singapore, Nourkrin maintains a presence through initiatives such as Hair Growth+ inCLINIC by Nourkrin®, which emphasizes the brand’s scientific heritage and Proteoglycan Replacement Therapy concept. 4

Nourkrin traces its research origins to 1978, beginning with investigations into the role of proteoglycans in regulating hair follicles. The development pathway involved research conducted in Denmark, Sweden, and Norway, leading to the creation of extraction and separation techniques for obtaining specific proteoglycan complexes from marine sources. This work culminated in the development of the Marilex® ingredient and the subsequent Nourkrin product line.

Current materials state that the research history exceeds 45 years, with more than 100 published scientific and clinical studies covering Nourkrin and its proteoglycan technology.

Proteoglycans and the Hair Cycle

The central scientific proposition behind Nourkrin involves proteoglycans, molecules found in connective tissues and extracellular matrices. Hair follicles undergo a repeating biological cycle consisting of:

1. Anagen: Active growth phase
2. Catagen: Transitional phase
3. Telogen: Resting phase
4. Exogen: Shedding phase

Nourkrin posits that specific proteoglycans regulate this cycle. The company refers to the depletion or alteration of these follicular proteoglycans as Proteoglycan Follicular Atrophy (PFA). The products are designed to supply bioactive proteoglycans to help restore the follicle’s environment and support the anagen (growth) phase.

Marilex®

Marilex® is the brand’s proprietary marine-derived complex. It is described as a fractionated fish extract containing specific lectican proteoglycans, produced via an enzymatic extraction process. Unlike standard multivitamins containing zinc or biotin, Nourkrin differentiates itself by delivering this specific bioactive marine complex associated with its replacement therapy theory.

Nourkrin WOMAN

Formulated primarily for women experiencing hair-growth disruption and thinning, this product centers on Marilex® and Proteoglycan Replacement Therapy. Applications discussed in research materials include female pattern hair loss, stress-related shedding, postpartum shedding, and other physiological disruptions.

Nourkrin MAN

This is the male-oriented formulation, featuring the proprietary complex Marilex-M®. According to product information, the daily serving provides: 2

• Marilex-M®: 720 mg
• Fenugreek: 100 mg
• Biotin: 180 μg

The recommended intake is two tablets per day, typically one in the morning and one in the evening with water after food, for a minimum of six months. Marilex-M® is designed to address biological processes associated with male hair follicle miniaturization.

There is published clinical literature regarding Nourkrin. A 2006 randomized, double-blind, placebo-controlled study involving 55 people with hair loss reported a statistically significant positive effect on hair growth during the six-month blinded phase, while also assessing tolerability. 3

More recent systematic reviews have included Nourkrin among oral nutritional interventions studied for hair loss. A 2022 review in JAMA Dermatology noted evidence suggesting potential benefit but emphasized limitations in the overall evidence base. Another meta-analysis found improvements in several hair-cycle measures, though total hair count did not reach statistical significance.

Reported Results

Nourkrin reports survey results from approximately 3,000 users, claiming:

• 63% reported significant improvement after 3 months
• 70% after 6 months
• 83% after 12 months

These are user-reported figures rather than randomized controlled trial data. The company also highlights a clinical study reporting a 35.7% increase in hair density after six months of treatment with Nourkrin containing Marilex®.

Nourkrin is positioned as a drug-free nutritional supplement, not a prescription medicine. It differs from pharmacological treatments like Minoxidil, Finasteride, or Dutasteride, which have distinct regulatory classifications and side-effect profiles. Consequently, individuals with significant or rapidly progressing hair loss should not assume a supplement substitutes for medical diagnosis or evidence-based treatment.

The brand recommends a treatment period of approximately six months, noting that initial effects may be noticeable after three months due to the slow nature of the hair-growth cycle. It is not marketed as a rapid solution.

Precise formulations vary by market. Nourkrin MAN lists Marilex-M®, Fenugreek extract, Biotin, and tablet excipients. Because Marilex-M® is derived from fish, the manufacturer states the product is not recommended for people allergic to fish. Ingredient lists may differ between countries.

Nourkrin occupies a niche between beauty, nutraceuticals, and medical hair-loss treatment. Its branding relies heavily on scientific terminology such as “Proteoglycan Replacement Therapy,” “Marilex®,” and references to dermatologists and trichologists. This creates a more clinical identity compared to typical “hair, skin & nails” vitamin brands.

In the competitive landscape, Nourkrin faces products like Viviscal, Nutrafol, Pantogar, and Lambdapil. Its primary differentiation remains its proprietary marine proteoglycan technology rather than generic vitamin content.

1. Nourkrin® – Frontpage
2. Nourkrin® MAN
3. Nourkrin: objective and subjective effects and tolerability in persons with hair loss – PubMed
4. Nourkrin Singapore